Antidepressant Treatment with Venlafaxine and Mirtazapine: no Effect on Serum Concentration of Vascular Endothelial Growth Factor (VEGF)

被引:4
|
作者
Deuschle, M. [1 ]
Gilles, M. [1 ]
Scharnholz, B. [1 ]
Kahl, K. G. [2 ]
机构
[1] Heidelberg Univ, Fac Med Mannheim, Cent Inst Mental Hlth, Mannheim, Germany
[2] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Hannover, Germany
关键词
vascular endothelial growth factor (VEGF); brain-derived neurotrophic factor (BDNF); depression; remission; antidepressant; NEUROTROPHIC FACTOR; DEPRESSION;
D O I
10.1055/s-0035-1555849
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Depression, stress and antidepressant treatment have been found to modulate the expression of growth factors. Methods: We studied depressed patients receiving randomized treatment with venlafaxine or mirtazapine for 28 days. Results: There was no significant difference between baseline VEGF concentrations in depressed patients compared to healthy controls. We found no significant effect of antidepressant treatment on serum VEGF. Discussion: In contrast to serum BDNF, VEGF may not be a suitable biomarker for effects of antidepressant treatment with venlafaxine or mirtazapine.
引用
收藏
页码:292 / 293
页数:2
相关论文
共 50 条
  • [31] Vascular endothelial growth factor (VEGF) expression and placental vascular response to VEGF
    Szukiewicz, D
    Szukiewicz, A
    Szewczyk, G
    Maslinski, S
    [J]. 22ND MEETING OF THE EUROPEAN SOCIETY FOR MICROCIRCULATION: MICROCIRCULATION AND VASCULAR BIOLOGY, 2002, : 277 - 280
  • [32] Expression of vascular endothelial growth factor (VEGF) and VEGF-C in serum and tissue of Wilms tumor
    Wang Lei
    Zhang Da
    Chen Xin-rang
    Fan Yu-xia
    Wang Jia-xiang
    [J]. CHINESE MEDICAL JOURNAL, 2011, 124 (22) : 3716 - 3720
  • [33] Maternal serum concentration of placental growth factor (PlGF), endothelial growth factor (VEGF) and VEGF receptor in isolated intrauterine growth restricted pregnancies
    Semezuk-Sikora, A.
    Krzyzanowski, A.
    Robak, J.
    Kraczkowski, J.
    Kwiatek, M.
    Semczuk, M.
    [J]. PROCEEDINGS OF THE 8TH WORLD CONGRESS OF PERINATAL MEDICINE, 2007, : 753 - 757
  • [34] Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas
    Roskoski, Robert, Jr.
    [J]. PHARMACOLOGICAL RESEARCH, 2017, 120 : 116 - 132
  • [35] EVALUATION OF SERUM CONCENTRATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN BREAST CANCER PATIENTS
    Hodorowicz-Zaniewska, Diana
    Kibil, Wojciech
    Malek, Agnieszka
    Szpor, Joanna
    Kulig, Jan
    Sztefko, Krystyna
    [J]. POLISH JOURNAL OF PATHOLOGY, 2012, 63 (04) : 255 - 260
  • [36] INVESTIGATION OF VASOACTIVE ENDOTHELIAL GROWTH FACTOR (VEGF) GENE POLYMORPHISM AND SERUM CONCENTRATION IN ENDOMETRIOSIS
    Attar, Rukset
    Attar, Erkut
    Yaylim-Eraltan, Ilhan
    Yilmaz-Aydogan, Hulya
    Agachan, Bedia
    Isbir, Turgay
    [J]. IUBMB LIFE, 2009, 61 (03) : 371 - 372
  • [37] Rapid Determination of Serum Vascular Endothelial Growth Factor (VEGF) by a Fluorescence Immunochromatographic Assay
    Wang, Shuo
    Lu, Hao
    Wang, Lei
    Zou, Jianping
    Zhang, Rong
    [J]. ANALYTICAL LETTERS, 2021, 54 (07) : 1233 - 1241
  • [38] Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients
    Heits, F
    Katschinski, DM
    Wiedemann, GJ
    Weiss, C
    Jelkmann, W
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (02) : 333 - 337
  • [39] Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression
    Viikki, Merja
    Anttila, Sami
    Kampman, Olli
    Illi, Ari
    Huuhka, Martti
    Setala-Soikkeli, Eija
    Mononen, Nina
    Lehtimaki, Terho
    Leinonen, Esa
    [J]. NEUROSCIENCE LETTERS, 2010, 477 (03) : 105 - 108
  • [40] The Investigation of the Effect of Topical Vascular Endothelial Growth Factor (VEGF) Administration On Serum Oxidative Parameters in Diabetic Rats
    Coban, Vildan Sonmez
    Cevher, Sule Coskun
    [J]. GAZI UNIVERSITY JOURNAL OF SCIENCE, 2016, 29 (03): : 543 - 547